Childhood cancer epidemiology in the Czech Republic (1994–2016)

J 2020

Childhood cancer epidemiology in the Czech Republic (1994–2016)

KREJČÍ, Denisa; Michaela ZAPLETALOVÁ; Ivana KATINOVÁ; Viera BAJČIOVÁ; Peter MÚDRY et al.

Základní údaje

Originální název

Childhood cancer epidemiology in the Czech Republic (1994–2016)

Autoři

KREJČÍ, Denisa; Michaela ZAPLETALOVÁ; Ivana KATINOVÁ; Viera BAJČIOVÁ; Peter MÚDRY; Vratislav ŠMELHAUS; Jaroslav ŠTĚRBA; Jan STARÝ; Riccardo CAPOCACCIA a Ladislav DUŠEK

Vydání

Cancer Epidemiology, Oxford, Elsevier, 2020, 1877-7821

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.984

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/20:00117433

Organizační jednotka

Lékařská fakulta

DOI

https://doi.org/10.1016/j.canep.2020.101848

UT WoS

000596559500004

EID Scopus

2-s2.0-85097112442

Klíčová slova anglicky

childhood cancer; incidence; mortality; survival; czech republic

Štítky

14110321, 14119612, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 4. 3. 2021 10:38, Mgr. Tereza Miškechová

Anotace

V originále

Background: The knowledge of cancer burden in the population, its time trends and the possibility of international comparison is an important starting point for cancer control programmes. Our study aimed to evaluate trends in childhood cancer epidemiology of patients aged 0–14 years in the period 1994–2016 in the Czech Republic. Methods: Data on childhood cancers have been obtained from the Czech National Cancer Registry. These data were validated using the clinical database of childhood cancer patients and combined with data from death certificates. Incidence and mortality trends were assessed by the joinpoint regression method. The life tables method was used to calculate the overall age-standardised five-year survival. Results: The incidence trend was stable; the age-standardised (world) cancer incidence – ASR (W) – was 173.7 per 1 million children in the period 1994–2016. However, there was apparent significant decrease in mortality: ASR (W) dropped from 58.1 per 1 million children in 1994 to 21.4 per 1 million children in 2016. The overall fiveyear survival increased over time by 10 %. Statistically significant improvements in survival were observed in patients with lymphoid leukaemia, astrocytomas, neuroblastomas, osteosarcomas and rhabdomyosarcomas. Conclusion: Such a relevant increase in survival rates, and therefore also a decrease in mortality rates in the Czech Republic, is most likely due to improvements in diagnostic and treatment methods since the 1990s, which were facilitated by the concentration of childhood cancer patients in children’s cancer centres.

Návaznosti

MUNI/A/1409/2019, interní kód MU

Název: Personalizovaná léčba v dětské onkologii: na cestě k "liquid dynamic medicine" a "N-of-1 clinical trials"

Investor: Masarykova univerzita, Personalizovaná léčba v dětské onkologii: na cestě k "liquid dynamic medicine" a "N-of-1 clinical trials", DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty

Citovat

KREJČÍ, Denisa; Michaela ZAPLETALOVÁ; Ivana KATINOVÁ; Viera BAJČIOVÁ; Peter MÚDRY; Vratislav ŠMELHAUS; Jaroslav ŠTĚRBA; Jan STARÝ; Riccardo CAPOCACCIA a Ladislav DUŠEK. Childhood cancer epidemiology in the Czech Republic (1994–2016). Cancer Epidemiology. Oxford: Elsevier, 2020, roč. 69, DEC 2020, s. 1-6. ISSN 1877-7821. Dostupné z: https://doi.org/10.1016/j.canep.2020.101848.

@article{1712136,
   author = {Krejčí, Denisa and Zapletalová, Michaela and Katinová, Ivana and Bajčiová, Viera and Múdry, Peter and Šmelhaus, Vratislav and Štěrba, Jaroslav and Starý, Jan and Capocaccia, Riccardo and Dušek, Ladislav},
   article_location = {Oxford},
   article_number = {DEC 2020},
   doi = {https://doi.org/10.1016/j.canep.2020.101848},
   keywords = {childhood cancer; incidence; mortality; survival; czech republic},
   language = {eng},
   issn = {1877-7821},
   journal = {Cancer Epidemiology},
   title = {Childhood cancer epidemiology in the Czech Republic (1994–2016)},
   url = {https://www.sciencedirect.com/science/article/abs/pii/S187778212030182X?via%3Dihub},
   volume = {69},
   year = {2020}
}

TY  - JOUR
ID  - 1712136
AU  - Krejčí, Denisa - Zapletalová, Michaela - Katinová, Ivana - Bajčiová, Viera - Múdry, Peter - Šmelhaus, Vratislav - Štěrba, Jaroslav - Starý, Jan - Capocaccia, Riccardo - Dušek, Ladislav
PY  - 2020
TI  - Childhood cancer epidemiology in the Czech Republic (1994–2016)
JF  - Cancer Epidemiology
VL  - 69
IS  - DEC 2020
SP  - 1-6
EP  - 1-6
PB  - Elsevier
SN  - 18777821
KW  - childhood cancer
KW  - incidence
KW  - mortality
KW  - survival
KW  - czech republic
UR  - https://www.sciencedirect.com/science/article/abs/pii/S187778212030182X?via%3Dihub
L2  - https://www.sciencedirect.com/science/article/abs/pii/S187778212030182X?via%3Dihub
N2  - Background: The knowledge of cancer burden in the population, its time trends and the possibility of international comparison is an important starting point for cancer control programmes. Our study aimed to evaluate trends in childhood cancer epidemiology of patients aged 0–14 years in the period 1994–2016 in the Czech Republic. Methods: Data on childhood cancers have been obtained from the Czech National Cancer Registry. These data were validated using the clinical database of childhood cancer patients and combined with data from death certificates. Incidence and mortality trends were assessed by the joinpoint regression method. The life tables method was used to calculate the overall age-standardised five-year survival. Results: The incidence trend was stable; the age-standardised (world) cancer incidence – ASR (W) – was 173.7 per 1 million children in the period 1994–2016. However, there was apparent significant decrease in mortality: ASR (W) dropped from 58.1 per 1 million children in 1994 to 21.4 per 1 million children in 2016. The overall fiveyear survival increased over time by 10 %. Statistically significant improvements in survival were observed in patients with lymphoid leukaemia, astrocytomas, neuroblastomas, osteosarcomas and rhabdomyosarcomas. Conclusion: Such a relevant increase in survival rates, and therefore also a decrease in mortality rates in the Czech Republic, is most likely due to improvements in diagnostic and treatment methods since the 1990s, which were facilitated by the concentration of childhood cancer patients in children’s cancer centres.
ER  -

KREJČÍ, Denisa; Michaela ZAPLETALOVÁ; Ivana KATINOVÁ; Viera BAJČIOVÁ; Peter MÚDRY; Vratislav ŠMELHAUS; Jaroslav ŠTĚRBA; Jan STARÝ; Riccardo CAPOCACCIA a Ladislav DUŠEK. Childhood cancer epidemiology in the Czech Republic (1994–2016). \textit{Cancer Epidemiology}. Oxford: Elsevier, 2020, roč.~69, DEC 2020, s.~1-6. ISSN~1877-7821. Dostupné z: https://doi.org/10.1016/j.canep.2020.101848.

Přehled o publikaci